Regeneron Pharmaceuticals Inc (REGN)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	4,412,600	4,654,500	4,321,700	3,857,800	3,953,600	3,991,100	4,299,000	4,182,700	4,338,400	5,370,300	5,686,800	7,933,600	8,075,300	6,995,500	6,205,400	4,003,800	3,513,200	3,156,000	2,983,500	2,279,300
Revenue (ttm)	US$ in thousands	14,185,900	13,812,700	13,436,900	13,029,000	13,044,200	13,025,200	12,601,200	12,306,100	12,113,500	13,654,100	14,171,800	16,451,800	16,014,400	13,499,700	12,328,800	9,147,000	8,455,000	8,201,600	7,974,500	7,957,900
Net profit margin		31.11%	33.70%	32.16%	29.61%	30.31%	30.64%	34.12%	33.99%	35.81%	39.33%	40.13%	48.22%	50.43%	51.82%	50.33%	43.77%	41.55%	38.48%	37.41%	28.64%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $4,412,600K ÷ $14,185,900K
= 31.11%

The net profit margin of Regeneron Pharmaceuticals Inc has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The net profit margin, which represents the percentage of revenue that translates into profit after accounting for all expenses, started at 28.64% in March 2020 and improved steadily, reaching its peak at 51.82% in September 2021.

However, after reaching the highest point, the net profit margin began to decline gradually. By December 31, 2024, the net profit margin decreased to 31.11%. Despite some fluctuations, the company has generally maintained a healthy level of profitability during this period.

It is essential for stakeholders to closely monitor the trends in net profit margin as it indicates how efficiently the company is managing its expenses relative to its revenue. Analyzing the net profit margin alongside other financial indicators can provide a more comprehensive understanding of Regeneron Pharmaceuticals Inc's overall financial performance and profitability sustainability.